Open Access. Powered by Scholars. Published by Universities.®

Medical Specialties Commons

Open Access. Powered by Scholars. Published by Universities.®

OncoLog MD Anderson's Report to Physicians (All issues)

Carcinoma, Non-Small-Cell Lung

Articles 1 - 13 of 13

Full-Text Articles in Medical Specialties

Oncolog, Volume 62, Number 05-06, May - June 2017, Joe Munch, Bryan Tutt, Kathryn Hale May 2017

Oncolog, Volume 62, Number 05-06, May - June 2017, Joe Munch, Bryan Tutt, Kathryn Hale

OncoLog MD Anderson's Report to Physicians (All issues)

  • Chimeric Antigen Receptor-Directed Natural Killer Cells for B Cell Malignancies: New take on an experimental therapy holds promise for patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, other lymphoid cancers.
  • Preoperative Exercise Program for Pancreatic Cancer Patients: Prehabilitation regimen to improve functional status during chemotherapy evaluated in clinical trials.
  • Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer: Clinical Trial will evaluate immune checkpoint inhibitors in patients with operable early-stage disease.
  • HOUSE CALL: Genetic Screening for Hereditary Cancer Syndromes: Genetic counseling, testing help people assess, manage cancer risk


Oncolog, Volume 61, Number 06, June 2016, Jill Deisigne, Joe Munch, Kathryn Hale, B Strubberg Jun 2016

Oncolog, Volume 61, Number 06, June 2016, Jill Deisigne, Joe Munch, Kathryn Hale, B Strubberg

OncoLog MD Anderson's Report to Physicians (All issues)

  • Proton Therapy Trials May Provide More Options for Patients with Non-Small Cell Lung Cancer: Proton therapy offers the potential to deliver a higher radiation dose to lung tumors and a lower dose to healthy tissues than does standard radiation therapy. However, the effectiveness of proton therapy has not yet been documented in clinical trials for patients with non-small cell lung cancer (NSCLC), the most common type of lung cancer. Two ongoing trials of proton therapy aim to demonstrate its effectiveness and may change the standard of care for NSCLC.
  • Innovative "Basket" Trial Shows Promise of BRAF Inhibition in Various Cancers: …


Oncolog, Volume 60, Number 08, August 2015, Stephanie Deming, Bryan Tutt, K. Nair Aug 2015

Oncolog, Volume 60, Number 08, August 2015, Stephanie Deming, Bryan Tutt, K. Nair

OncoLog MD Anderson's Report to Physicians (All issues)

  • New Gene Therapy for Bladder Cancer Shows Promise: A gene therapy that stimulates interferon production within the body may prove to be effective against high-risk, early-stage bladder cancer when standard treatment fails.
  • Vaccine Helps T Cells Target Sarcomas, Melanomas and other Tumors: A vaccine that delivers an antigen to dendritic cells, in turn activating killer T cells that can target specific cancers, is the subject of two ongoing clinical trials,
  • INBRIEF: Glypican-1 Shows Promise as a Biomarker for Pancreatic Cancer/Stereotactic Ablative Radiation Therapy for Stage I Non-Small Cell Lung Cancer May Offer Survival Benefit
  • HOUSE CALL: Prostate Cancer Screening-Who should …


Oncology, Volume 56, Number 10, October 2011, Bryan Tutt, Sunni Hosemann Oct 2011

Oncology, Volume 56, Number 10, October 2011, Bryan Tutt, Sunni Hosemann

OncoLog MD Anderson's Report to Physicians (All issues)

  • Treating Cancer in Pregnant Patients: Pregnancy is usually a joyous, hopeful time; a cancer diagnosis can be devastating. When pregnancy and cancer occur together, they present special challenges for patients and physicians. Fortunately, these challenges often can be overcome by a multidisciplinary approach to treatment
  • Compass: Non-Small Cell Lung Cancer: Stage IIIA-Many factors affect treatment sequences
  • HOUSE CALL: Understanding Cancer Risk and Risk Factors: Your risk factors might affect your need for cancer screening


Oncolog Volume 55, Number 09, September 2010, Sunita Patterson, John Lebas Sep 2010

Oncolog Volume 55, Number 09, September 2010, Sunita Patterson, John Lebas

OncoLog MD Anderson's Report to Physicians (All issues)

  • Tiny Particales, vast Potential-Coming soon to the clinic: nanoparticles that deliver therapy straight to tumor cells, bypassing normal cells and many toxic effects
  • Non-Hodgkin Lymphomas: Targeted Therapies Leading Treatment Advances
  • HOUSE CALL: Writing for Wellness: Keeping a Journal
  • INBRIEF: Study Shows Abnormal Cells in Blood Increase with Lung Cancer Stage


Oncolog Volume 55, Number 08, August 2010, Bryan Tutt, John Lebas Aug 2010

Oncolog Volume 55, Number 08, August 2010, Bryan Tutt, John Lebas

OncoLog MD Anderson's Report to Physicians (All issues)

  • Therapeutic Vaccines against Cancer: Clinical trials of thrapeutic vaccines in cancer patients yield positive results
  • Findings Could Altere Chronic Myelogenous Leukemia Treatment: Phase III trials show newer drugs yield better responses than imatinib
  • INBRIEF: Vandetanib Shows Benefit When Combined with Docetaxel for Lung Cancer/ HPV-Positive Tumor Status Indicates Better Prognosis in Patients with Oropharyngeal Cancer
  • HOUSE CALL: Understanding the Benefits and Risks of Massage


Oncolog Volume 55, Number 06, June 2010, John Lebas Jun 2010

Oncolog Volume 55, Number 06, June 2010, John Lebas

OncoLog MD Anderson's Report to Physicians (All issues)

  • The BATTLE Results Are IN: Phase II trial reveals molecular signatures in lung cancer that may guide treatment decisions.
  • Endoscopic Repair of Colon Perforations: Nonsurgical techniques for closing gestrointestinal defects may yiels benefits for patients undergoing colonoscopy.
  • INBRIEF: Stem Cells Seen Repairing Heart Attack Damage Over Time/Additional Blood Data May Improve Pediatric Leukemia Predictions/Pediatric Patients with Rare Tumor May benefit from Heated Chemotherapy/New Findings Refute Link Between UVA, Melanoma.
  • HOUSE CALL: Skin Cancer Screening: What is It and Who Should Get It ?: Types of skin cancer/Who should be screened ?/What to expect/Self-examination: Check your skin regularly and tell your …


Oncolog Volume 54, Number 11/12, November/December 2009, Dawn Chalaire, Joe Munch Nov 2009

Oncolog Volume 54, Number 11/12, November/December 2009, Dawn Chalaire, Joe Munch

OncoLog MD Anderson's Report to Physicians (All issues)

  • Treating Neurofibromatosis
  • Personalized Therapy for Lung Cancer
  • House Call: Genetic Screening for Cancer Risks Gives Patients Options


Oncolog, Volume 52, Number 09, September 2007, Sunni Hosemann, Diane Witter, Gabriel N. Hortobagyi Md Jan 2007

Oncolog, Volume 52, Number 09, September 2007, Sunni Hosemann, Diane Witter, Gabriel N. Hortobagyi Md

OncoLog MD Anderson's Report to Physicians (All issues)

  • Sparing Life and Limb
  • Can a Common Spice Be Use to Treat Cancer?
  • House Call: Your First Colonoscopy: Here's What You Can Expect
  • DiaLog: Targeted Therapies Are Here to Stay, by Gabriel N. Hortobagyi, MD


Oncolog, Volume 50, Number 12, December 2005, Sunni Hosemann, Diane Witter Dec 2005

Oncolog, Volume 50, Number 12, December 2005, Sunni Hosemann, Diane Witter

OncoLog MD Anderson's Report to Physicians (All issues)

  • Moving New Drugs from "Bench to Bedside and Back"
  • House Call: When the End Is Near: Ways to Cope When a Loved One Is Terminally Ill
  • After Katrina: Caring for Cancer Patients in the Wake of the Storm


Oncolog, Volume 49, Number 06, June 2004, Kate O'Suilleabhain, Katie Prout Matias, Jack Roth Md Jun 2004

Oncolog, Volume 49, Number 06, June 2004, Kate O'Suilleabhain, Katie Prout Matias, Jack Roth Md

OncoLog MD Anderson's Report to Physicians (All issues)

  • Despite Initial Setbacks, Researchers Are Focusing on Antiangiogenic Therapy More Than Ever
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging Predicts Response to Antiangiogenesis Agents
  • "Smart Bombs": Targeted Therapies Home in on Increasingly Well-Defined Targets
  • House Call: Understanding Angiogenesis
  • DiaLog: Gene Therapy for Cancer: Safety First, by Jack Roth, MD, Chair, Department of Thoracic and Cardiovascular Surgery


Oncolog, Volume 41, Number 02, April-June 1996, Kathryn L. Hale, Stephanie P. Deming Jan 1996

Oncolog, Volume 41, Number 02, April-June 1996, Kathryn L. Hale, Stephanie P. Deming

OncoLog MD Anderson's Report to Physicians (All issues)

  • lntraoperative lymphatic mapping elegant way to identify lymph node metastases in melanoma patients
  • New Patient Referral Office changes with M. D. Anderson's referral policy
  • Combined chemotherapy and radiation therapy bringing hope for inoperable lung cancer


Oncolog, Volume 33, Number 03, July-September 1988, C. Stratton Hill, Jr. Md Jan 1988

Oncolog, Volume 33, Number 03, July-September 1988, C. Stratton Hill, Jr. Md

OncoLog MD Anderson's Report to Physicians (All issues)

  • Narcotics and Cancer Pain Control
  • For Non-small Cell Lung Cancer, Combinations of Surgery, Chemotherapy, and Radiotherapy
  • Shared Research Resources Provide Expertise and Cost Savings